首页 > 最新文献

BJU International最新文献

英文 中文
Matched‐pair analysis of peri‐operative and oncological outcomes of robot‐assisted vs open retroperitoneal lymph node dissection
IF 4.5 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-04-22 DOI: 10.1111/bju.16747
Pailin Pongratanakul, Marieke Vermeulen‐Spohn, Carolin Wöltjen, Sophia Thy, Andreas Hiester, Peter Albers, Yue Che
ObjectiveTo analyse a comparatively large cohort of patients who underwent robot‐assisted retroperitoneal lymph node dissection (R‐RPLND) in a single centre, assessing the peri‐operative and oncological safety of this procedure compared to that in a matched‐pair cohort of patients who underwent open retroperitoneal lymph node dissection (O‐RPLND).MethodsWe retrospectively identified 100 patients who underwent R‐RPLND between October 2010 and January 2024. A matched‐pair analysis of R‐RPLNDs and O‐RPLNDs was conducted based on the following criteria: surgical indication, histology, clinical stage (CS), and tumour size. The primary endpoint of this analysis was progression‐free survival (PFS). Secondary endpoints were peri‐operative parameters.ResultsBased on surgical indication, the R‐RPLND cohort was divided into four groups: CS II seminoma (Group 1, 42 patients); marker‐negative CS II non‐seminoma (Group 2, 15 patients); CS I non‐seminoma with high‐risk factors (Group 3, seven patients), and post‐chemotherapy patients (Group 4, 34 patients). Two patients were excluded due to uncommon testicular histology. With a mean follow‐up of 32, 31, 32 and 28 months in the four groups, respectively, relapses occurred in 10/42 of Group 1, 3/15 of Group 2, and 1/7 of Group 3, while all patients remained relapse‐free in Group 4. The matched‐pair analysis revealed that histological retroperitoneal lymph node dissection specimens, relapse rates, and PFS were similar in the R‐RPLND and O‐RPLND groups. R‐RPLND had advantages in terms of a shorter hospital stay as a surrogate for less morbidity.ConclusionIn selected patients and selected surgical indications, R‐RPLND represents a minimally invasive alternative to O‐RPLND in the management of patients with testicular germ cell tumours.
{"title":"Matched‐pair analysis of peri‐operative and oncological outcomes of robot‐assisted vs open retroperitoneal lymph node dissection","authors":"Pailin Pongratanakul, Marieke Vermeulen‐Spohn, Carolin Wöltjen, Sophia Thy, Andreas Hiester, Peter Albers, Yue Che","doi":"10.1111/bju.16747","DOIUrl":"https://doi.org/10.1111/bju.16747","url":null,"abstract":"ObjectiveTo analyse a comparatively large cohort of patients who underwent robot‐assisted retroperitoneal lymph node dissection (R‐RPLND) in a single centre, assessing the peri‐operative and oncological safety of this procedure compared to that in a matched‐pair cohort of patients who underwent open retroperitoneal lymph node dissection (O‐RPLND).MethodsWe retrospectively identified 100 patients who underwent R‐RPLND between October 2010 and January 2024. A matched‐pair analysis of R‐RPLNDs and O‐RPLNDs was conducted based on the following criteria: surgical indication, histology, clinical stage (CS), and tumour size. The primary endpoint of this analysis was progression‐free survival (PFS). Secondary endpoints were peri‐operative parameters.ResultsBased on surgical indication, the R‐RPLND cohort was divided into four groups: CS II seminoma (Group 1, 42 patients); marker‐negative CS II non‐seminoma (Group 2, 15 patients); CS I non‐seminoma with high‐risk factors (Group 3, seven patients), and post‐chemotherapy patients (Group 4, 34 patients). Two patients were excluded due to uncommon testicular histology. With a mean follow‐up of 32, 31, 32 and 28 months in the four groups, respectively, relapses occurred in 10/42 of Group 1, 3/15 of Group 2, and 1/7 of Group 3, while all patients remained relapse‐free in Group 4. The matched‐pair analysis revealed that histological retroperitoneal lymph node dissection specimens, relapse rates, and PFS were similar in the R‐RPLND and O‐RPLND groups. R‐RPLND had advantages in terms of a shorter hospital stay as a surrogate for less morbidity.ConclusionIn selected patients and selected surgical indications, R‐RPLND represents a minimally invasive alternative to O‐RPLND in the management of patients with testicular germ cell tumours.","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"46 1","pages":""},"PeriodicalIF":4.5,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143857481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robot‐assisted MRI/US fusion transperineal prostate biopsy using the Biobot system: a single‐centre experience
IF 4.5 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-04-21 DOI: 10.1111/bju.16742
Gabriele Bignante, David O. Katz, William A. Langbo, Angelo Orsini, Francesco Lasorsa, Edward E. Cherullo, Riccardo Autorino, Srinivas Vourganti
{"title":"Robot‐assisted MRI/US fusion transperineal prostate biopsy using the Biobot system: a single‐centre experience","authors":"Gabriele Bignante, David O. Katz, William A. Langbo, Angelo Orsini, Francesco Lasorsa, Edward E. Cherullo, Riccardo Autorino, Srinivas Vourganti","doi":"10.1111/bju.16742","DOIUrl":"https://doi.org/10.1111/bju.16742","url":null,"abstract":"","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"49 1","pages":""},"PeriodicalIF":4.5,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143853532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long‐term follow‐up reveals complexity of urinary and faecal continence outcomes in patients with classic bladder exstrophy 长期随访揭示典型膀胱外翻患者大小便失禁后果的复杂性
IF 4.5 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-04-21 DOI: 10.1111/bju.16752
Mao Liao, Molan Li
{"title":"Long‐term follow‐up reveals complexity of urinary and faecal continence outcomes in patients with classic bladder exstrophy","authors":"Mao Liao, Molan Li","doi":"10.1111/bju.16752","DOIUrl":"https://doi.org/10.1111/bju.16752","url":null,"abstract":"","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"28 1","pages":""},"PeriodicalIF":4.5,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143853531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
External validation of current quality care metrics after radical nephroureterectomy
IF 4.5 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-04-20 DOI: 10.1111/bju.16741
Igor Duquesne, Pierre-Etienne Gabriel, Mohamad Abou Chakra, Mohamad Moussa, Raymond Mansour, Mihnea Bogdan Borz, Louise Duffaut, Benoit Mesnard, Said Ourfali, Jeremy Mercier, Michaël Peyromaure, Alexandre de la Taille, Jérôme Rigaud, Alain Ruffion, Frédéric Panthier, Evanguelos Xylinas, Alexandra Masson-Lecomte, Morgan Rouprêt, Thomas Seisen, Mathieu Roumiguié
To externally validate the tetrafecta and pentafecta frameworks for assessing the quality of radical nephroureterectomy (RNU) and their correlation with oncological outcomes in patients with localised upper tract urothelial carcinoma (UTUC).
从外部验证用于评估根治性肾切除术(RNU)质量的四分法和五分法框架及其与局部上尿路上皮癌(UTUC)患者肿瘤预后的相关性。
{"title":"External validation of current quality care metrics after radical nephroureterectomy","authors":"Igor Duquesne, Pierre-Etienne Gabriel, Mohamad Abou Chakra, Mohamad Moussa, Raymond Mansour, Mihnea Bogdan Borz, Louise Duffaut, Benoit Mesnard, Said Ourfali, Jeremy Mercier, Michaël Peyromaure, Alexandre de la Taille, Jérôme Rigaud, Alain Ruffion, Frédéric Panthier, Evanguelos Xylinas, Alexandra Masson-Lecomte, Morgan Rouprêt, Thomas Seisen, Mathieu Roumiguié","doi":"10.1111/bju.16741","DOIUrl":"https://doi.org/10.1111/bju.16741","url":null,"abstract":"To externally validate the tetrafecta and pentafecta frameworks for assessing the quality of radical nephroureterectomy (RNU) and their correlation with oncological outcomes in patients with localised upper tract urothelial carcinoma (UTUC).","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"34 1","pages":""},"PeriodicalIF":4.5,"publicationDate":"2025-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143853638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term cost-effectiveness of invasive urodynamic studies for overactive bladder in women
IF 4.5 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-04-19 DOI: 10.1111/bju.16703
Helen Bell-Gorrod, Praveen Thokala, Suzanne Breeman, David Cooper, Graeme MacLennan, Mohamed Abdel-Fattah, Simon Dixon
To estimate the cost-effectiveness of using invasive urodynamic studies (UDS) in the management of women with refractory overactive bladder (OAB) symptoms using the results of the FUTURE trial.
{"title":"Long-term cost-effectiveness of invasive urodynamic studies for overactive bladder in women","authors":"Helen Bell-Gorrod, Praveen Thokala, Suzanne Breeman, David Cooper, Graeme MacLennan, Mohamed Abdel-Fattah, Simon Dixon","doi":"10.1111/bju.16703","DOIUrl":"https://doi.org/10.1111/bju.16703","url":null,"abstract":"To estimate the cost-effectiveness of using invasive urodynamic studies (UDS) in the management of women with refractory overactive bladder (OAB) symptoms using the results of the FUTURE trial.","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"23 1","pages":""},"PeriodicalIF":4.5,"publicationDate":"2025-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143849370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perioperative complications of focal therapy for prostate cancer: results from the GeRmAn Nationwide inpatient Data (GRAND) study
IF 4.5 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-04-19 DOI: 10.1111/bju.16746
Nikolaos Pyrgidis, Michael Chaloupka, Benedikt Ebner, Yannic Volz, Philipp Weinhold, Julian Marcon, Lennert Eismann, Christian G. Stief, Gerald B. Schulz, Maria Apfelbeck
To compare the perioperative complications of the most common focal therapy (FT) modalities for prostate cancer.
比较最常见的前列腺癌病灶治疗(FT)模式的围手术期并发症。
{"title":"Perioperative complications of focal therapy for prostate cancer: results from the GeRmAn Nationwide inpatient Data (GRAND) study","authors":"Nikolaos Pyrgidis, Michael Chaloupka, Benedikt Ebner, Yannic Volz, Philipp Weinhold, Julian Marcon, Lennert Eismann, Christian G. Stief, Gerald B. Schulz, Maria Apfelbeck","doi":"10.1111/bju.16746","DOIUrl":"https://doi.org/10.1111/bju.16746","url":null,"abstract":"To compare the perioperative complications of the most common focal therapy (FT) modalities for prostate cancer.","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"44 1","pages":""},"PeriodicalIF":4.5,"publicationDate":"2025-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143849371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of treatment for muscle-invasive bladder cancer on health-related quality of life
IF 4.5 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-04-16 DOI: 10.1111/bju.16736
Siberyn T. Nuijens, Lisa M.C. van Hoogstraten, Noëlle B. Terpstra, Ivy Beeren, Alina Vrieling, Eveline M. Wijnen, Richard P. Meijer, Lambertus A. Kiemeney, J. Alfred Witjes, Katja K.H. Aben
To evaluate the impact of treatment for localised muscle-invasive bladder cancer (MIBC) during the first 2 years after diagnosis.
{"title":"The impact of treatment for muscle-invasive bladder cancer on health-related quality of life","authors":"Siberyn T. Nuijens, Lisa M.C. van Hoogstraten, Noëlle B. Terpstra, Ivy Beeren, Alina Vrieling, Eveline M. Wijnen, Richard P. Meijer, Lambertus A. Kiemeney, J. Alfred Witjes, Katja K.H. Aben","doi":"10.1111/bju.16736","DOIUrl":"https://doi.org/10.1111/bju.16736","url":null,"abstract":"To evaluate the impact of treatment for localised muscle-invasive bladder cancer (MIBC) during the first 2 years after diagnosis.","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"3 1","pages":""},"PeriodicalIF":4.5,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143841294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to “Recent advancements in the Ward AdmSsion of Haematuria: an observational mUlticentre sTudy (WASHOUT)—a large‐scale observational multicentre study of inpatient haematuria”
IF 4.5 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-04-16 DOI: 10.1111/bju.16745
{"title":"Correction to “Recent advancements in the Ward AdmSsion of Haematuria: an observational mUlticentre sTudy (WASHOUT)—a large‐scale observational multicentre study of inpatient haematuria”","authors":"","doi":"10.1111/bju.16745","DOIUrl":"https://doi.org/10.1111/bju.16745","url":null,"abstract":"","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"1 1","pages":""},"PeriodicalIF":4.5,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143836700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combating online misinformation in clinical encounters
IF 4.5 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-04-15 DOI: 10.1111/bju.16734
Stacy Loeb, Mariana Rangel Camacho, Tatiana Sanchez Nolasco, Nataliya Byrne, Adrian Rivera, LaMont Barlow, June Chan, Scarlett Gomez, Aisha T. Langford

Disclosure of Interests

Stacy Loeb reports a research grant from Endo, and consulting with Astellas, Blue Earth, Endo, Doceree, and Savour Health, unrelated to the present manuscript. The remaining authors have no disclosures.

利益披露Stacy Loeb报告获得了恩度公司的研究基金,并与安斯泰来、Blue Earth、恩度、Doceree和Savour Health等公司有咨询关系,但与本稿件无关。其余作者未披露任何信息。
{"title":"Combating online misinformation in clinical encounters","authors":"Stacy Loeb, Mariana Rangel Camacho, Tatiana Sanchez Nolasco, Nataliya Byrne, Adrian Rivera, LaMont Barlow, June Chan, Scarlett Gomez, Aisha T. Langford","doi":"10.1111/bju.16734","DOIUrl":"https://doi.org/10.1111/bju.16734","url":null,"abstract":"<h2> Disclosure of Interests</h2>\u0000<p>Stacy Loeb reports a research grant from Endo, and consulting with Astellas, Blue Earth, Endo, Doceree, and Savour Health, unrelated to the present manuscript. The remaining authors have no disclosures.</p>","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"7 1","pages":""},"PeriodicalIF":4.5,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143837065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous nephrolithotomy: wisdom, dogma, paradigm and myths surrounding puncture
IF 4.5 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-04-15 DOI: 10.1111/bju.16740
Peter Alken
<p>A non-transpapillary technique [<span>1</span>] seems to facilitate access to the kidney, the most crucial aspect of percutaneous nephrolithotomy, compared to the classic transpapillary method [<span>2</span>].</p><p>In modern times, the godfathers of percutaneous access, Goodwin et al. [<span>3</span>], who illustrated a pyelostomy rather than a nephrostomy in Fig. 2 of their 1955 article, should be commended for their non-papillary puncture.</p><p>From the contemporary first accounts of ‘experience with a central, noncalyceal puncture protocol for percutaneous nephrolithotripsy’ [<span>4</span>] in 2017, a myth has persisted that has carried through to all subsequent studies on the subject, including the study by Lotfi et al. [<span>1</span>], that the ‘Current understanding of anatomical background of percutaneous access is based mostly on the very extensive documentation by Sampaio’ [<span>4</span>].</p><p>By the time of Sampaio's publications, 15 years after the introduction of endoscopic PNL in the late 1970s, several thousand PNLs had probably been performed worldwide based on the transpapillary principle. The first instruments specifically designed in 1980 for endoscopically controlled PNL [<span>2</span>] followed two principles: Access through the least vascularised part of the parenchyma and access with the nephrosocpe into the collecting system at the point where it is connected to the parenchyma, i.e. the collecting system itself should not be injured. The aim was to avoid vascular trauma and extravasation and also to reach even the most peripherally located calyceal stone.</p><p>This was the reversal of the least traumatic way to place a nephrostomy tube into the collecting system from the point of view of a urologist influenced by having previously performed open surgery. In the times of open surgery, a forceps was pushed transpapillary from the calyx, an anatomically preformed tract, to the surface of the kidney in order to pull the nephrostomy tube into the collecting system. In the late 1960s, John Wickham [<span>5</span>] added the open transpapillary avascular multiple radial nephrotomies technique for the removal of staghorn calculi to this decades-old transpapillary technique. This was later refined by a team at the University of Mainz, who performed staghorn surgery without clamping the renal artery, utilising only transpapillary access.</p><p>In PNL, I have not always hit the mark with a perfect transpapillary approach when carrying out PNL, but was sometimes happy simply to obtain access (Fig. 1). In one of his many articles on open stone surgery, Wickham described ‘Large venous anastomoses … like collars around the calyceal necks.’ In my experience and that of others (Tursunkulov AN, Akfamedline University Hospital, Central Asian University, Tashkent; personal communication), this description fits the annoying venous oozing frequently observed behind the nephroscope when using the non-papillary access method, whi
与经典的经毛细血管穿刺法[2]相比,非毛细血管穿刺技术[1]似乎更容易进入肾脏,这是经皮肾镜碎石术最关键的方面。在现代,经皮入路的教父Goodwin等人[3]在1955年的文章图2中展示了肾盂造口术而非肾造口术,他们的非毛细血管穿刺技术值得称赞。从 2017 年 "经皮肾镜碎石术中央非肾盏穿刺方案的经验"[4] 的首次当代描述开始,一个神话就一直存在,并一直延续到所有后续的相关研究,包括 Lotfi 等人的研究[1],即 "当前的经皮肾镜碎石术中央非肾盏穿刺方案"[5]。[Sampaio发表文章时,也就是 20 世纪 70 年代末内镜下肾镜碎石术问世 15 年后,全世界大概已经根据经皮肾镜碎石术原理实施了数千例肾镜碎石术。1980 年,第一批专为内镜控制 PNL 而设计的器械[2] 遵循了两个原则:从血管最少的实质部分进入,并在肾实质与集合系统连接处用肾镜进入集合系统,即不能损伤集合系统本身。从泌尿科医生的角度来看,这是将创伤最小的肾造瘘管置入集合系统的逆转之举。在开放手术时代,为了将肾造瘘管拉入收集系统,需要将镊子从肾萼(解剖学上预先形成的管道)经肾盂推至肾脏表面。20 世纪 60 年代末,John Wickham[5]在已有几十年历史的经毛细血管切开技术的基础上,增加了开放性经毛细血管无血管多径向肾切开术,用于清除鹿角状结石。后来,美因茨大学的一个团队对这一技术进行了改进,他们在不夹闭肾动脉的情况下,仅利用经毛细血管入路进行了鹿角状结石手术。在进行 PNL 时,我并不总能以完美的经毛细血管入路达到目的,但有时仅获得入路就很高兴(图 1)。Wickham 在其众多关于开放结石手术的文章中描述道:"大的静脉吻合口......就像套在萼颈上的项圈。根据我和其他人的经验(Tursunkulov AN,塔什干中亚大学 Akfamedline 大学医院;个人通信),这一描述与使用非毛细血管入路方法时经常在肾镜后观察到的恼人静脉渗出相吻合。只要是静脉渗出,这只是暂时的问题。图 1在图形浏览器中打开PowerPoint "乐于获取入路",尽管采用了经肾盂入路,但随后由于肾门动脉病变导致混合性尿瘤血肿而造成肾脏移位。例如,Tahra 等人报告说,"为了达到无结石状态,减少不必要的入路......",他们在 11 年的 PNL 经验中,对 207 名患者使用非乳头入路,对 69 名患者使用乳头入路[6]。或者,正如 Cracco 和 Scoffone 睿智地指出的那样:还要考虑到常规为 PCNL 进行乳头穿刺的内镜医师肯定不会在 100%的病例中进行完美的穿刺,因此目前的文献实际上包括了数千例'真正乳头'和'半乳头'穿刺的结果"[7]。本研究的作者总结道[1]:"非乳头入路可在不同可行入路获取技术的背景下加以考虑,尤其是在乳头入路不可行或技术上具有挑战性的情况下。"然而,我仍然不满意 "瞄准更大的区域(肾盏、肾底和肾盂)而非单点(肾盏顶端)"[4]。灾难并不一定经常发生,但它会对患者和外科医生产生重大影响。Sampaio 于 1988 年指出,"在腔内肾结石清除术中,解剖学是最容易被忽视的一个方面"[8]。
{"title":"Percutaneous nephrolithotomy: wisdom, dogma, paradigm and myths surrounding puncture","authors":"Peter Alken","doi":"10.1111/bju.16740","DOIUrl":"https://doi.org/10.1111/bju.16740","url":null,"abstract":"&lt;p&gt;A non-transpapillary technique [&lt;span&gt;1&lt;/span&gt;] seems to facilitate access to the kidney, the most crucial aspect of percutaneous nephrolithotomy, compared to the classic transpapillary method [&lt;span&gt;2&lt;/span&gt;].&lt;/p&gt;\u0000&lt;p&gt;In modern times, the godfathers of percutaneous access, Goodwin et al. [&lt;span&gt;3&lt;/span&gt;], who illustrated a pyelostomy rather than a nephrostomy in Fig. 2 of their 1955 article, should be commended for their non-papillary puncture.&lt;/p&gt;\u0000&lt;p&gt;From the contemporary first accounts of ‘experience with a central, noncalyceal puncture protocol for percutaneous nephrolithotripsy’ [&lt;span&gt;4&lt;/span&gt;] in 2017, a myth has persisted that has carried through to all subsequent studies on the subject, including the study by Lotfi et al. [&lt;span&gt;1&lt;/span&gt;], that the ‘Current understanding of anatomical background of percutaneous access is based mostly on the very extensive documentation by Sampaio’ [&lt;span&gt;4&lt;/span&gt;].&lt;/p&gt;\u0000&lt;p&gt;By the time of Sampaio's publications, 15 years after the introduction of endoscopic PNL in the late 1970s, several thousand PNLs had probably been performed worldwide based on the transpapillary principle. The first instruments specifically designed in 1980 for endoscopically controlled PNL [&lt;span&gt;2&lt;/span&gt;] followed two principles: Access through the least vascularised part of the parenchyma and access with the nephrosocpe into the collecting system at the point where it is connected to the parenchyma, i.e. the collecting system itself should not be injured. The aim was to avoid vascular trauma and extravasation and also to reach even the most peripherally located calyceal stone.&lt;/p&gt;\u0000&lt;p&gt;This was the reversal of the least traumatic way to place a nephrostomy tube into the collecting system from the point of view of a urologist influenced by having previously performed open surgery. In the times of open surgery, a forceps was pushed transpapillary from the calyx, an anatomically preformed tract, to the surface of the kidney in order to pull the nephrostomy tube into the collecting system. In the late 1960s, John Wickham [&lt;span&gt;5&lt;/span&gt;] added the open transpapillary avascular multiple radial nephrotomies technique for the removal of staghorn calculi to this decades-old transpapillary technique. This was later refined by a team at the University of Mainz, who performed staghorn surgery without clamping the renal artery, utilising only transpapillary access.&lt;/p&gt;\u0000&lt;p&gt;In PNL, I have not always hit the mark with a perfect transpapillary approach when carrying out PNL, but was sometimes happy simply to obtain access (Fig. 1). In one of his many articles on open stone surgery, Wickham described ‘Large venous anastomoses … like collars around the calyceal necks.’ In my experience and that of others (Tursunkulov AN, Akfamedline University Hospital, Central Asian University, Tashkent; personal communication), this description fits the annoying venous oozing frequently observed behind the nephroscope when using the non-papillary access method, whi","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"136 1","pages":""},"PeriodicalIF":4.5,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143832018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BJU International
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1